Coyne Terrance P.

EVP & CFORoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.4M
Net Open-Market Flow
-$10.4M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Sell(S)1K$43.29$47K23K
Feb 4, 2026Sell(S)19K$43.29$826K165K
Feb 3, 2026Sell(S)6K$42.84$265K24K
Feb 3, 2026Sell(S)109K$42.84$4.7M184K
Feb 2, 2026Sell(S)6K$42.08$246K30K
Feb 2, 2026Sell(S)103K$42.08$4.3M292K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814876-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: